Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid β/A4 peptide

Clements, A and Walsh, D M and Williams, C H and Allsop, D (1993) Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid β/A4 peptide. Neuroscience Letters, 161 (1). pp. 17-20. ISSN 0304-3940

Full text not available from this repository.

Abstract

We assessed the fibrillogenic properties of synthetic peptides corresponding to residues 13-26 of beta/A4 amyloid, containing either the normal sequence (beta 13 26) or the mutations Glu22 to Gln (beta 13-26Q22) and Ala21 to Gly (beta 13-26G21). The kinetics of aggregation were monitored at 37 degrees C and pH 7.4 by measuring the amount of peptide remaining in solution, using reverse-phase high performance liquid chromatography. Negative stain electron microscopy revealed that all of the peptides formed fibrils. However, beta 13-26Q22 showed greatly accelerated fibril formation compared to the other two. The results suggest that the Q22 mutation confers increased amyloidogenic properties on the beta/A4 peptide, whereas the G21 mutation acts by a different pathogenic mechanism.

Item Type:
Journal Article
Journal or Publication Title:
Neuroscience Letters
Uncontrolled Keywords:
/dk/atira/pure/subjectarea/asjc/2800/2800
Subjects:
?? alaninealzheimer diseaseamino acid sequenceamyloidamyloid beta-peptidesglutamatesglutamic acidglycinehumansmolecular sequence datamutationgeneral neuroscienceneuroscience(all) ??
ID Code:
50844
Deposited By:
Deposited On:
07 Nov 2011 16:57
Refereed?:
Yes
Published?:
Published
Last Modified:
16 Jul 2024 08:57